Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001247728 | SCV001421168 | likely benign | Spondylocostal dysostosis 3, autosomal recessive | 2024-01-11 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002568681 | SCV003686314 | uncertain significance | Inborn genetic diseases | 2021-09-17 | criteria provided, single submitter | clinical testing | The c.1021C>T (p.R341W) alteration is located in exon 7 (coding exon 7) of the LFNG gene. This alteration results from a C to T substitution at nucleotide position 1021, causing the arginine (R) at amino acid position 341 to be replaced by a tryptophan (W). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Laboratory of Diagnostic Genome Analysis, |
RCV001796413 | SCV002036221 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001796413 | SCV002037970 | likely benign | not provided | no assertion criteria provided | clinical testing |